Technology
Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.
By Katherine Langford
MarketWatch
Advertisement
Wall Street is fleeing tech for toothpaste and shampoo. Even those stocks are getting expensive.